Vanguard Global Advisers »

C4 Therapeutics shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $89k 34k 2.63

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding C4 Therapeutics

Morgan Stanley
RA Capital Management
Bain Capital Life Sciences Investors
Lynx1 Capital Management
Vanguard Group
Vanguard Capital Management
Soleus Capital Management
Two Sigma Investments
Daniel D. Thurber
Citadel Advisors
Goldman Sachs Group
Bank of America Corporation
Squadron Capital Management
BlackRock
Silverarc Capital Management

View all funds holding C4 Therapeutics